Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)

Summary

This study hypothesizes that the administration of Sodium zirconium cyclosilicate in CKD patients with hyperkalemia while avoiding dietary potassium restriction will normalize their serum potassium levels. Additionally, we aim to assess the effects of a high potassium diet on renal function, endothelial function, acidosis, systemic inflammatory status and gut microbiota.

Timeline

Start

2021-03-15

Primary completion

2022-01-15

Completion

2022-01-15

Drugs

Indications